SONIA PARKER: Open Payments
NPI 1083035562 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,286 in 52 payments from 14 companies in 2025. Trend: 2023 $1,902 · 2024 $2,442 · 2025 $2,286
Food & beverage: $2,286
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $512 |
| Novo Nordisk Inc | 4 | $348 |
| Novartis Pharmaceuticals Corporation | 10 | $201 |
| Merck Sharp & Dohme LLC | 2 | $141 |
| Esperion Therapeutics, Inc. | 6 | $134 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $123 |
| Madrigal Pharmaceuticals | 1 | $123 |
| ABBVIE INC. | 1 | $120 |
Products named: Repatha, LEQVIO, NEXLETOL, BREZTRI, DUPIXENT, AREXVY, Wegovy, REZDIFFRA.
Industry payments across CA — which companies pay providers there.
